Iohexol API Market
Iohexol API Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Iohexol API Market Size and Growth
The Iohexol API market is experiencing steady growth due to increasing diagnostic imaging demands and expanding healthcare infrastructure. As of 2023, the market size is estimated at approximately USD 150 million, driven by rising prevalence of chronic diseases and technological advancements in contrast media, enhancing imaging efficacy and patient outcomes.
Companies Covered
(Covid 19 Impact Covered)
◍ GE Healthcare
◍ BeiLu Pharma
◍ Fuji Pharma
◍ Stellite
◍ Haichang Pharmaceutical
The Iohexol API market features key players like GE Healthcare, BeiLu Pharma, Fuji Pharma, Stellite, and Haichang Pharmaceutical. These companies manufacture Iohexol for diagnostic imaging, enhancing market growth through innovative formulations and expanded applications. Notable sales figures include GE Healthcare's $19 billion and BeiLu Pharma's approximate $800 million in annual revenue.
Request Sample Report
Market Segmentation
By Application
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
